1.
Discovery of SIAIS178 as an Effective BCR-ABL Degrader by Recruiti..
[3117]
|
2.
Discovery and characterization of novel potent BCR-ABL degraders b..
[779]
|
3.
PROTEIN DEGRADATION TARGETING COMPOUND, ANTI-TUMOR APPLICATION, ..
[627]
|
4.
ALK PROTEIN REGULATOR AND ANTI-TUMOR APPLICATION THEREOF
[621]
|
5.
PROTEIN DEGRADATION TARGETING COMPOUND, ANTI-TUMOR APPLICATION, ..
[620]
|
6.
Protein degradation targeting compound, anti-tumor application, ..
[603]
|
7.
Discovery of a Brigatinib Degrader SIAIS164018 with Destroying Met..
[571]
|
8.
Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase..
[541]
|
9.
PROTEIN DEGRADATION TARGETING BCR-ABL COMPOUND AND ANTITUMOR APPLI..
[505]
|
10.
蛋白降解靶向化合物、其抗肿瘤应用、其中间体及中间体应用
[489]
|
11.
TARGET PROTEIN DEGRADATION COMPOUNDS, THEIR ANTI-TUMOR USE, THEI..
[457]
|
12.
COMPOUNDS TARGETING AND DEGRADING BCR-ABL PROTEIN AND ITS ANTITUMO..
[456]
|
13.
TARGET PROTEIN DEGRADATION COMPOUNDS, THEIR ANTI-TUMOR USE, THEI..
[437]
|
14.
Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase..
[414]
|
15.
ALK蛋白调节剂及其抗肿瘤应用
[397]
|
16.
ALK蛋白降解剂及其抗肿瘤应用
[394]
|
17.
ALK蛋白降解剂及其抗肿瘤应用
[393]
|
18.
ALK蛋白调节剂及其抗肿瘤应用
[370]
|
19.
ALK PROTEIN DEGRADERS AND THEIR USE IN CANCER THERAPY
[364]
|
20.
ALK protein degradation agent and anti-tumor application thereof
[364]
|
21.
靶蛋白降解化合物及其抗肿瘤用途,中间体和中间体
[363]
|
22.
ALK proteolytic agents and their use in cancer therapy
[361]
|
23.
ALK PROTEIN DEGRADATION AGENT AND ANTI-TUMOR APPLICATION THEREOF
[340]
|
24.
ALK蛋白调节剂及其抗肿瘤应用
[336]
|
25.
蛋白降解靶向化合物、其抗肿瘤应用、其中间体及中间体应用
[331]
|
26.
ALK蛋白调节剂及其抗肿瘤应用
[327]
|
27.
ALK蛋白调节剂及其抗肿瘤应用
[322]
|
28.
ALK蛋白降解剂及其抗肿瘤应用
[320]
|
29.
The proteolytic agent for use in the therapy of cancer and ALK
[286]
|
30.
The target proteolytic compounds, its anti-tumor applications, i..
[273]
|
31.
蛋白降解靶向BCR-ABL化合物及其抗肿瘤应用
[220]
|
32.
靶蛋白降解化合物、其抗肿瘤用途、其中间体及其用途
[102]
|